Literature DB >> 27153843

Medication and aggressiveness in "real world" schizophrenia: current issues and perspectives.

Guillaume Fond1, Laurent Boyer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27153843     DOI： 10.1007/s00213-016-4303-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  8 in total

1.  What's wrong with quality-of-life measures? A philosophical reflection and insights from neuroimaging.

Authors:  Laurent Boyer; Karine Baumstarck; Eric Guedj; Pascal Auquier
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2014-10-01       Impact factor: 2.217

2.  The denial of aggression in violent patients with schizophrenia.

Authors:  Menahem I Krakowski; Pal Czobor
Journal:  Schizophr Res       Date:  2012-09-23       Impact factor: 4.939

3.  Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.

Authors:  G Fond; L Boyer; M Favez; L Brunel; B Aouizerate; F Berna; D Capdevielle; I Chereau; J M Dorey; C Dubertret; C Faget; F Gabayet; H Laouamri; C Lancon; Y Le Strat; D Misdrahi; R Rey; C Passerieux; A Schandrin; F Schurhoff; A M Tronche; M Urbach; P Vidalhet; P M Llorca; A Pelissolo
Journal:  Psychopharmacology (Berl)       Date:  2015-12-03       Impact factor: 4.530

4.  Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective study.

Authors:  Guillaume Fond; Sebastien Guillaume; Sylvaine Artero; Paquito Bernard; Grégory Ninot; Philippe Courtet; Xavier Quantin
Journal:  J Affect Disord       Date:  2012-12-23       Impact factor: 4.839

5.  Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment.

Authors:  Karine Baumstarck; Laurent Boyer; Mohamed Boucekine; Valérie Aghababian; Nathalie Parola; Christophe Lançon; Pascal Auquier
Journal:  Schizophr Res       Date:  2013-04-06       Impact factor: 4.939

6.  Cortical thinning, functional connectivity, and mood-related impulsivity in schizophrenia: relationship to aggressive attitudes and behavior.

Authors:  Matthew J Hoptman; Daniel Antonius; Cristina J Mauro; Emily M Parker; Daniel C Javitt
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

7.  Prevalence and smoking behavior characteristics of nonselected smokers with childhood and/or adult self-reported ADHD symptoms in a smoking-cessation program: a cross-sectional study.

Authors:  Guillaume Fond; Sebastien Guillaume; Isabelle Jaussent; Severine Beziat; Alexandra Macgregor; Paquito Bernard; Philippe Courtet; Daniel Bailly; Xavier Quantin
Journal:  J Atten Disord       Date:  2013-08-13       Impact factor: 3.256

8.  The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.

Authors:  T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Matthew J Byerly; Ira D Glick; Jose M Canive; Mark F McGee; George M Simpson; Michael C Stevens; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.